TUMORMARKER UND VERWENDUNG DAVON
European patent · EP4006171 · In force
Register entry
- Publication number
- EP4006171
- Application number
- EP20846161
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 28, 2020
- Published
- Jun 1, 2022
- Granted
- Dec 10, 2025
- Protection ends at the latest
- Jul 27, 2040
- Next annual fee due
- Jul 31, 2026
- IPC classes
- C12Q 1/6886 (2018.01)C12N 15/11 (2006.01)
- Priority
- CN 201910695955 30.07.2019
- PCT application
- PCT/CN2020/105047 28.07.2020
- PCT publication
- WO2021/018116 04.02.2021
- Filing language
- Chinese
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 21, 2026
Change
Published in Swissreg on 21.10.2026
- Dec 10, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 10.12.2025
Parties
Inventor
CHENG, Tong
Wuxi, Jiangsu 214000, CN
ZHOU, Ning
Wuxi, Jiangsu 214000, CN
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.